These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
989 related articles for article (PubMed ID: 19697436)
1. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436 [TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599 [TBL] [Abstract][Full Text] [Related]
3. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Iversen LH; Rasmussen PC; Laurberg S Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824 [TBL] [Abstract][Full Text] [Related]
4. Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneal chemotherapy: state of the art and future prospects. Di Carlo I; Pulvirenti E; Sparatore F; Toro A; Cordio S Surg Oncol; 2007 Dec; 16 Suppl 1():S145-8. PubMed ID: 18023575 [TBL] [Abstract][Full Text] [Related]
5. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140 [TBL] [Abstract][Full Text] [Related]
6. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686 [TBL] [Abstract][Full Text] [Related]
7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619 [TBL] [Abstract][Full Text] [Related]
8. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730 [TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis. Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034 [TBL] [Abstract][Full Text] [Related]
10. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Franko J; Gusani NJ; Holtzman MP; Ahrendt SA; Jones HL; Zeh HJ; Bartlett DL Ann Surg Oncol; 2008 Nov; 15(11):3065-72. PubMed ID: 18712450 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up]. Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624 [TBL] [Abstract][Full Text] [Related]
12. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations. Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796 [TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813 [TBL] [Abstract][Full Text] [Related]
14. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Chua TC; Yan TD; Zhao J; Morris DL Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081 [TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer. Gervais MK; Dubé P; McConnell Y; Drolet P; Mitchell A; Sideris L J Surg Oncol; 2013 Dec; 108(7):438-43. PubMed ID: 24018983 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy. Verwaal VJ Cancer J; 2009; 15(3):212-5. PubMed ID: 19556907 [TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence. Lefevre JH; Elias DM Cancer J; 2009; 15(3):200-3. PubMed ID: 19556905 [TBL] [Abstract][Full Text] [Related]
19. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival. Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321 [TBL] [Abstract][Full Text] [Related]
20. Hidden opportunities in cytoreductive surgery for peritoneal carcinomatosis of colorectal origin. Chang GJ; Lambert LA Ann Surg Oncol; 2008 Nov; 15(11):2993-5. PubMed ID: 18787903 [No Abstract] [Full Text] [Related] [Next] [New Search]